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Abstract: Non-thermal plasma is a future tool for the treatment of cancer, some diseases, and for many medical 
applications. Dielectric Barrier Discharge Plasma (DBDP) is a type of plasma that has been used for the treatment of 
cancers in different researches. In this work (DBDP) was used to evaluate its effect on Colon Cancer Cell-line (CaCo Cell-
line), through three doses depending on the time of exposure (40, 60, and 80 sec.). After exposure, the cell-line were 
cultured for 72 hours and followed by two types of analysis. The first was MTT assay for the determination of cell 
viability. The second was molecular analysis for two genes associated with cancers; Caspase 9 gene (apoptotic gene) and 
Bax gene (pro-apoptotic gene) through detection of their proteins. The results of the study proved that the DBD Plasma has 
a strong killing effect on the cancer cell-line (CaCo), and this effect increased with the time of exposure increased. The 
study proved also that; the effect of DBDP coming from its effect on the transcription of genes associated with cancer, 
where the study found that the degree of transcription of Caspase 9 and Bax genes was significantly increased as the result 
of the exposure. Therefore, the results of this study make us consider that DBD Plasma Device is a promised tool for the 
treatment of cancer, where the plasma promotes the process of apoptosis in cancer cells.  
 




The plasma concept is created by shedding high voltage 
energy to the gaseous state that atoms strike together and 
diminish their electrons [1]. Plasma has a complicated 
structure, It contains a group of electrons, ions, excited and 
neutralization atoms, ultraviolet (UV), free radicals, 
thermal, infrared radiation, electric fields, and molecules 
[2].  
Several investigations have proved the antitumor 
effectiveness of plasma on various kinds of cancer cells [3-
4]. 
Over the past decade, cold atmospheric plasma (CAP), 
ionized gas near room temperature has a promising 
application in cancer therapy. Two devices, dielectric 
barrier discharge and plasma jet show a significant anti-
cancer effect on many different cancer cell-lines (in vitro) 
and several subcutaneous xenograft tumors (in vivo). In  
 
 
contrast to conventional anti-cancer approaches and drugs, 
cold atmospheric plasma is a selective anti-cancer modality 
[5]. 
In vitro plasma-exposed eukaryotic cells demonstrate 
several effects such as cell migration alteration and 
apoptosis or necrosis according to cell type and exposure 
parameters (power, time of exposure) [6]. 
Different studies suggested that cancer cells are more 
sensitive to cold atmospheric plasma treatment than normal 
cells concluding a selective decrease in cancer cell viability 
with less cytotoxic effect on nonmalignant cells [7]. 
Cold atmospheric plasma includes physical effects 
(production of ultraviolet, and electromagnetic fields) and 
beside chemical components (production of RONS). 
Whereas the physical effects seem to have a negligible 
cellular impact [8], but RONS may induce cell membrane 
alterations, where the increase of the intracellular ROS, 
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leads to the decrease of the antioxidant potential and DNA 
double-strand brakes and subsequently apoptosis [9].Many 
basic cellular responses following cold atmospheric plasma 
are( apoptosis, growth inhibition, selective cancer cell 
death, cell cycle arrest, DNA and mitochondrial damage, 
selective increase of ROS or even immunogenic cell death) 
[10]. 
The Bax gene translates a protein which upon activation 
changes the mitochondria in the cell to motivate cell death 
[11]. 
Upon activation, the Bax gene leads to depolarize the 
membrane and to leak the mitochondria to its contents like 
cytochrome C [12]. And these lead to changes in the form 
or, the structure of the apoptotic cell which is called 
morphological differences such as shrinkage and nuclear 
condensation, i.e. the shrinkage of the cell and the bleeding 
of the membrane, and these changes lead to the release of 
vesicles consists of the cellular ingredients which will be 
swallow by living cells [13]. 
The Caspase-9 gene is the fundamental initiator Caspase 
that is responsible for the programmed cell death or 
mitochondrial apoptosis path [14]. Under exposure to the 
apoptosis exciters inside the cell, the cytochrome C is 
released by the mitochondria. The activated Caspase-9 can 
stimulate the executioner Caspases (Caspase-3, Caspase-6,  
and Caspase-7) and release a cascade of steps causing 

















2 Materials and Methods 
2.1 Experimental Setup  
 
The current study was performed in the Biological 
applications Department, Plasma and Nuclear Fusion 
Department in the Egyptian Atomic Energy Authority. 
The electrical circuit of the DBD plasma device consists of 
a High Voltage (HV) power supply of voltage up to 15 kV 
Alternating Current (AC), a frequency of 50 Hz is 
connected to a variable resistance controller to adjust the 
input voltage and a charging resistor of 10 kΩ. The input 
voltage is connected to the HV electrode (anode) via the 
HV probe of attenuation ratio 1000:1 linked to a digital 
oscilloscope [16].The biomedical device of the DBD 
plasma mainly contains the HVAC power supply, two 
electrodes, and a glass dielectric as shown in Fig. 1(a). The 
upper electrode is made of iron and the lower electrode 
facing the sample is made of iron mesh. They are separated 
by 2 mm thick glass. 
Fig. 1(b) illustrates the construction of the DBD plasma 
apparatus where the diameter of the HV electrode is a 6 cm 
iron plate. Plasma is transferred from a source located at a 
constant distance of 5 cm up the treated sample; the plasma 
is generated as an electrical discharge results from the 
electrical breakdown of argon gas in the gap between the 
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The distance between the sample (cell-line) and the ground 
electrode was 5 cm. the gas of plasma was argon, the 
atmospheric temperature was 38 oC. The exposure time of 
the samples was as the following: 
First sample: Control sample, non-exposed. 
Second sample: Cell-line exposed for 40 sec.  
Third sample: Cell-line exposed for 60 sec.  
Fourth sample: Cell-line exposed for 80 sec. 
After treatment, each Cell-line sample was divided into 7 
portions, and they were cultured for 3 days, then the 
determination of the viability of the cell-lines groups for all 
samples were obtained by MTT assay. 
I. MTT Assay: 
Cytotoxicity activity was evaluated for CaCo cells via MTT 
3-(4,5-Dimethylthiazol-2yL)-2,5 Diphenyl tetrazolium 
bromide) assay (MTT assay kit(cell proliferation) Abcam, 
(ab 211391) to Horiuchi et al.,(1988) [17,18] as follow:- 
1. Cells (1x105 /well) were plated in 0.2 mL of 
medium /well in 96-well plates. 
2. Removing medium from the wells carefully after 
incubation. 
3. Washing each well with MEM (W/O) FCS 2-3 
times and 200µL of MTT (5 mg/ml) was added. 
4. Incubating plates for 6-7 hrs. in 5% CO2 incubator 
for cytotoxicity. 
5. Adding 1 mL of DMSO (Solubilizing reagent) was 
to each well and mixed well by micro-pipette and 
























6. The presence of viable cells was visualized by the 
development of purple color due to the formation 
of formazan crystals. 
7. Transferring suspension to the cuvette of a 
spectrophotometer and the OD (Optical Density) 
values were read at 595 nm by using DMSO as a 
blank. 
8. Measurements were performed and the 
concentration required for a 50% inhibition of 
viability (IC50) was determined graphically.  The 
standard graph was plotted by taking the dose of 
treatment on the x-axis and relative cell viability 
on the y-axis.  
 
The viability of the cell (%) = x100. 
 
After determination of viability, the cells were going for 
another analysis (molecular analysis). 
The molecular analysis included proteomics analysis of 
caspase-9 and Bax genes. 
II. Molecular assay (proteomics analysis): 
The proteomics analysis included two genes the caspase-9 
gene and the Bax gene  
 as the following: 
Blotting technique:  
1- Total soluble proteins for all samples were purified 
through tri fast( peq lap VWR company)[isolation of 
RNA, DNA, and protein simultaneously] 
2- Blotting Solutions: 
         a- Blotting buffers:  
25 mM Tris, pH 7.4, 0.15 M NaCl and 0.1% Tween 20 
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         b- Blocking solution:  
2-5% nonfat dry milk in Blotting Buffer Adjust pH to 7.4 
         c- Antibody solution:  
1-5% nonfat dry milk in Blotting Buffer Adjust pH to 7.4 
 3. Blotting protocol: 
Electrophoresed proteins on SDS-PAGE were transferred to 
a Hybond™ nylon membrane (GE Healthcare) via TE62 
Standard Transfer Tank with Cooling Chamber (Hoefer 
Inc. and incubate for 1 hour at room temperature in 
Blocking Solution. Additionally, β-actin was applied as a 
housekeeping protein.  
4. The membrane was incubated overnight at 4°C in 
Antibody Solution containing Anti- Caspase 9 primary 
antibody (Abcam, USA, ab25758), and Anti-Bax 
(ab232479). For normalizing data, Anti- β-actin primary 
antibody (Abcam, ab228001) was used. 
5. The membrane was washed at room temperature for 30-
60 minutes with 5 changes of Blotting Buffer. 
6. The membrane was incubated for 1 hour at room 
temperature in Antibody Solution containing appropriate 
dilution of HRP-conjugated secondary antibody (Antibody 
concentration. 0.1-0.5 microgram/mL. Adjust antibody 
concentration from 0.05 to 2.0 microgram/mL to obtain 
desired signal strength and low background. 
7. The membrane was washed for 30-60 minutes with 5 
changes of Blotting Buffer. 
The technique is called the Western Blot Protocol 
References [19, 20, and 21]. 
Data analysis: 
Gel documentation system (Geldocit, UVP, England) was 
applied for data analysis using totallab analysis software, 
www.tatallab.com (ver. 1.0.1) [22]. 
3 Results 
3.1 Statistical Analysis 
The obtained data were presented as mean ±SE. One-way 
analysis of variance (ANOVA) was carried out using a 
statical package program (COSTAT). A probability level of 
p ˂ 0.05 was considered. 
The results of viability were as the following: 
Table 1 The mean value of viability (%) for all groups. The 
values of G1, G2, G3, and G4 represent the percent of 
changes regarding normal control group 1. 
 
Groups 
Control 40 sec 60 sec 80 sec 
G1 ±SE G2 ±SE G3 ±SE G4 ±SE 
Viability 95±1.3(a) 81±2.6(b) 57±2.4(c) 55±2.4(c) 
 
 
Fig. 2 Mean value of viability (%) for all groups. 
Table 1 and Fig. 2 represent the percent of changes related 
to the normal control group. Comparing to the normal 
control group, the levels of viability showed a significant 
decrease in all treated groups (G2, G3, and G4). At the same 
time, the levels of changes were highly significant in G3 and 
G4 (60 seconds and 80 seconds of exposure time) 
respectively. 
  i.e. increasing the time of exposure leads to good 
treatment. 
1. Caspase-9 gene 
   
 
Fig. 3 The indication level of caspase-9 for CaCo cell line 
protein of four treatments. 
Table 2: data parameters for the indication level of 
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Fig. 4 Computerized detection of the indication level of 
caspase-9 for CaCo cell line protein of four treatments. 
 
Fig. 5 the indication level of caspase-9 of CaCo cell line for 
four treatments. 
1. Bax gene: 
 
Fig. 6 Bax protein expression level for CaCo cell line 
protein of four treatments. 
 
 
Fig. 7 Computerized detection of the indication level of 
Bax protein for CaCo cell line protein of four treatments. 
Table 3: data parameters of the indication level of Bax 





G2 ±SE G3 ±SE G4 ±SE 











Fig. 8 The indication level of Bax protein of CaCo cell line 
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Fig. 9 β-actin protein expression level for CaCo cell line 
protein of four treatments. 
 
Fig. 10 Computerized detection of β-actin protein 
expression level for CaCo cell line protein of four 
treatments. 
Table 4 data parameters of β-actin protein expression level 
for CaCo cell line protein with four treatments. 
Groups G1(control)  G2  G3  G4 
β-actin 10.25 10.37 10.77 10.12 
 
4 Discussions 
Plasma is an ionizing gas that contains charged particles 
such as electrons, ions, electronically excited molecules, 
and atoms, free radicals, and UV photons. Plasma treating 
exposes tissue surface or cells to active long and short-lived 
neutral atoms and molecules, including singlet oxygen (O2), 
ozone (O3), OH radicals, and NO, and a remarkable flowing 
of charged particles, including both positive ions,  negative 
ions, and electrons [23]. 
Our physical cells are generated by the mitosis process and 
nearly all will stop living or die by the apoptosis process 
that is a physiological process of cell to commits suicide. 
Cancer happens when this equilibrium is disturbed, either 
by the reduction of cell death or the rising in cell 
reproduction. The purpose of cancer treatment is to increase 
the death of cancer cells without further destruction of the 
living cells. [24]. 
The results of this study proved that Dielectric barrier 
discharge plasma has a strong killing effect on malignant 
cells (Table 1 and Fig. 2) where the viability of colon 
cancer cells (CaCo) was significantly decreased as the 
result of exposure, and increasing the time of exposure 
leads to good treatment. 
For supporting this result with another analysis (molecular 
protein analysis of two genes associated with cancer), and 
to know the mechanism of action for DBD plasma on 
cancer cells the study proved that; the DBD plasma 
exposure induces protein transcription of the Bax gene 
(pro-apoptotic gene) as shown in Table 3 and Fig.6 and the 
level of transcription increased with increasing time of 
exposure. 
The same result was found in the case of Caspase 9 gene 
transcription (apoptotic gene), where the level of protein 
densities was significantly increased as the result of 
exposure, and increasing the dose of exposure increase the 
level of protein transcription (Table 2 and Fig. 5). This 
means that; the plasma induces apoptosis and cell 
programmed death of the malignant cells, giving finally 
more degradation of cancer cells. 
The result of this study is in agreement with many studies 
where a significant portion of human breast cancer cells 
was observed to exhibit apoptosis fragmentation with the 
application of a pulsed atmospheric pressure plasma jet. 
The apoptotic effect depends mainly on the components of 
the plasma plume [25]. 
In another study, a comparison of cancerous cells with their 
non-cancerous counterparts was performed to determine the 
selectivity of treatment. Through analysis of seven human 
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cell lines (cancerous; A549, U87, A375, and Malme-3M; 
non-cancerous: BEAS-2B, HA, and HEMA) and five 
different cell culture media (DMEM, PRMI 1640, AM, 
BEGM, and DCBM) revealed that the tested parameters 
influence indirect cold atmospheric plasma treatment, while 
direct treatment was less affected. The study demonstrated 
that cell type, cancer type, and culturing medium must be 
taking into account [26]. 
The conclusion of this study stated that Dielectric Barrier 
Discharge Plasma has a selectivity degradative effect on 
cancer cells through inducing the apoptosis process and 
able to destroy cancer cells without any damage to healthy 
cells. 
  In comparison between the densities of resulted protein 
(transcription) of the Caspase -nine gene between different 
doses of treatment and control group (see Fig. 7 and Table. 
2, it was found that group 3 and group 4 (60 seconds and 80 
seconds of exposure time) significantly increased which 
means that, the DBD plasma increase the transcription level 
of Caspase-9 (Apoptotic gene). 
Increasing the level of this gene leads to an increase in the 
level of degradation of cancer cells. 
Regarding the Bax gene, the densities of G3 and G4 (60 
seconds and 80 seconds of exposure time) were highly 
significant increase in comparison with the control group 
(see Fig. 12, Table 3). 
This result indicates the same result of the Caspase-nine 
gene, and the result of the two genes illustrates that the 
exposure time of the cell-line to DBD plasma induces the 
transcription of Apoptotic and pro-apoptotic genes which 
resulted in a killing effect on malignancy with different 
degrees according to the dose of exposure. 
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